ComplianceOnline

Drug Product Performance, In Vivo: Bioavailability and Bioequivalence

Instructor: Leon Shargel
Product ID: 705461
Training Level: Basic
  • 26
  • October 2017
    Thursday
  • 10:00 AM PDT | 01:00 PM EDT
    Duration: 90 Min

Live Online Training
October 26, Thursday 10:00 AM PDT | 01:00 PM EDT | Duration: 90 Min

$199.00
One Dial-in One Attendee
$529.00
Group-Max. 10 Attendees/Location
(For Multiple Locations Contact Customer Care)
Super Deal - Get CD free!

recorded version

$249.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training

Training CD

$349.00
One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days after completion of Live training

Combo Offers

Live + Recorded Version

$349.00

Live + Training CD

$449.00

Customer Care

Fax: +1-650-565-8542

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This webinar will discuss the basic concepts of bioavailability and bioequivalence and their relationship to drug product performance, in vivo. It will also provide practical examples to show how bioavailability and bioequivalence studies can be applied to drug product development.

Why Should You Attend:

Bioavailability is a measure of the rate and amount of drug that gets systemically absorbed and is available to the site of action. The ability to quantitate drug bioavailability and to compare drug bioavailability (bioequivalence) to different formulations of the same drug provide evidence that drug product performance is consistent and will produce a predictable therapeutic effect. These studies are used for the development of new drug formulations and for the development of generic drug products as part of the regulatory requirement for therapeutic equivalence.

This webinar will provide an understanding of the measurement of bioavailability, the design of bioequivalence studies, the statistical evaluation of the results and how these results relate to the development of new and generic drug products. Practical examples will emphasize the types of drug substances and drug products that have bioavailability and/or bioequivalence problems.

The webinar will also discuss whether bioequivalence studies are needed for all drugs, for different drug doses and for post-approval formulation changes.

Areas Covered in the Webinar:

  • Drug product performance and drug product quality
  • Absolute and relative bioavailability
  • Bioavailability and bioequivalence as measures of in vivo drug product performance
  • Bioequivalence studies in new drug and generic drug development
  • Methods for the measurement of bioavailability
  • Statistical designs for bioequivalence studies
  • Statistical criteria for bioequivalence and evaluation of the data
  • Therapeutic equivalence and generic drug product approval
  • Bio waivers and rationale for not to performing bioequivalence studies
  • Scale up and post approval studies (SUPAC)
  • Issues in demonstrating bioequivalence for specialized drug substances and drug products

Who Will Benefit:

This webinar will provide valuable assistance to personnel working as bench chemist/analyst, supervisor, manager, director or vice president in pharmaceutical manufacturing facilities, including laboratories and associated contract organizations, of innovator and generic companies for human and animal products, in the following areas:

  • Pharmaceutical Development
  • Setting up Analytical Methods (Pharmacopeial, regulatory or in-house developed)
  • R & D, both analytical and formulation
  • Project Management
  • Quality Control
  • Quality Assurance
  • Regulatory Affairs
Instructor Profile:
Leon Shargel

Leon Shargel
Manager and Founder, Applied Biopharmaceutics LLC

Leon Shargel, Ph.D., R.Ph., is a Manager and Founder of Applied Biopharmaceutics LLC, a pharmaceutical consulting company and holds academic appointments as Affiliate Professor, School of Pharmacy, Virginia Commonwealth University. Prior to forming his own company, Dr. Shargel was Vice President, Biopharmaceutics, Sandoz (formerly, Eon Labs).

Dr. Shargel has over 35 years’ experience in both academia and the pharmaceutical industry. Dr. Shargel has lectured widely on pharmacokinetics, bioavailability and generic drug product development. He has over 200 publications including a leading textbook, “Applied Biopharmaceutics & Pharmacokinetics.”

Dr. Shargel received a B.S. in Pharmacy from the University of Maryland and a Ph.D. in Pharmacology from the George Washington University Medical Center. He is a member of various professional societies including the American Association Pharmaceutical Scientists (AAPS), American Pharmacists Association (APhA) and the American Society for Pharmacology and Experimental Therapeutics (ASPET).

Topic Background:

Drug product performance, in vivo, is defined as the release of the drug substance from the drug product leading to the bioavailability of the drug. The evaluation of drug product performance relates bioavailability to the therapeutic response and adverse events. Bioavailability and bioequivalence studies are measurements of drug product performance and can be used to evaluate new drug formulations, changes in drug formulations and development of generic drug products.

Follow us :
Upcoming In-person Seminars by EX-FDA OFFICIALS
Method Development and Validation for Assays Supporting Testing of Biologics

More Trainings by Expert

Pharmacokinetics of Oral Absorption

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading